Collateral: Gene therapy past is not prologue

The rap on gene therapy has been that it sounds good, but doesn't yet work in practice: expression levels aren't high enough, some vectors cause inflammatory responses, and so on.

Collateral Therapeutics believes that it has technology that has overcome past shortcomings of gene therapy and the preclinical data to answer any objections...